Demonstrating a reduced capacity for removal of fluid from cerebral white matter and hypoxia in areas of white matter hyperintensity associated with age and dementia.
Aged
Aged, 80 and over
Aging
/ pathology
Amyloid beta-Peptides
/ metabolism
Animals
Dementia
/ pathology
Extracellular Fluid
/ metabolism
Female
Fibronectins
/ metabolism
Glymphatic System
/ pathology
Humans
Hypoxia, Brain
/ pathology
Laminin
/ metabolism
Male
Mice
Mice, Inbred C57BL
Muscle, Smooth, Vascular
/ metabolism
White Matter
/ pathology
Fibronectin
Intramural periarterial drainage
Laminin
White matter hyperintensities
Journal
Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673
Informations de publication
Date de publication:
08 08 2020
08 08 2020
Historique:
received:
17
06
2020
accepted:
01
08
2020
entrez:
11
8
2020
pubmed:
11
8
2020
medline:
1
6
2021
Statut:
epublish
Résumé
White matter hyperintensities (WMH) occur in association with dementia but the aetiology is unclear. Here we test the hypothesis that there is a combination of impaired elimination of interstitial fluid from the white matter together with a degree of hypoxia in WMH. One of the mechanisms for the elimination of amyloid-β (Aβ) from the brain is along the basement membranes in the walls of capillaries and arteries (Intramural Peri-Arterial Drainage - IPAD). We compared the dynamics of IPAD in the grey matter of the hippocampus and in the white matter of the corpus callosum in 10 week old C57/B16 mice by injecting soluble Aβ as a tracer. The dynamics of IPAD in the white matter were significantly slower compared with the grey matter and this was associated with a lower density of capillaries in the white matter. Exposing cultures of smooth muscle cells to hypercapnia as a model of cerebral hypoperfusion resulted in a reduction in fibronectin and an increase in laminin in the extracellular matrix. Similar changes were detected in the white matter in human WMH suggesting that hypercapnia/hypoxia may play a role in WMH. Employing therapies to enhance both IPAD and blood flow in the white matter may reduce WMH in patients with dementia.
Identifiants
pubmed: 32771063
doi: 10.1186/s40478-020-01009-1
pii: 10.1186/s40478-020-01009-1
pmc: PMC7414710
doi:
Substances chimiques
Amyloid beta-Peptides
0
Fibronectins
0
Laminin
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
131Subventions
Organisme : Medical Research Council
ID : G1000691
Pays : United Kingdom
Organisme : MRC CFAS
ID : MRC U.1052.00.0013
Pays : International
Organisme : MRC CFAS
ID : MRC/G9901400
Pays : International
Organisme : Medical Research Council
ID : G0601022
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9901400
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L022656/1
Pays : United Kingdom
Références
Acta Neuropathol. 2018 Jul;136(1):139-152
pubmed: 29754206
Brain Res. 2018 Dec 1;1700:78-85
pubmed: 30006296
Acta Neuropathol. 2010 Mar;119(3):277-90
pubmed: 20155424
Exp Neurol. 2013 Dec;250:270-81
pubmed: 24103194
Matrix Biol. 2002 Aug;21(5):399-414
pubmed: 12225805
Neuropathology. 2003 Jun;23(2):111-8
pubmed: 12777099
Nat Immunol. 2017 Feb;18(2):123-131
pubmed: 28092374
Brain Pathol. 2015 Jan;25(1):63-78
pubmed: 25521178
Neuropathol Appl Neurobiol. 2011 Feb;37(1):75-93
pubmed: 20946241
Brain Res Bull. 1981 Nov;7(5):519-79
pubmed: 7317796
Front Aging Neurosci. 2016 Sep 27;8:223
pubmed: 27729857
J Am Heart Assoc. 2015 Jun 23;4(6):001140
pubmed: 26104658
Acta Neuropathol Commun. 2019 Feb 7;7(1):16
pubmed: 30732655
Radiat Res. 1987 May;110(2):161-72
pubmed: 3575649
Physiol Rev. 2005 Jul;85(3):979-1000
pubmed: 15987800
Acta Neuropathol. 2009 Jan;117(1):1-14
pubmed: 19002474
BMC Bioinformatics. 2017 Nov 29;18(1):529
pubmed: 29187165
Acta Neuropathol. 2011 Apr;121(4):431-43
pubmed: 21259015
J Neuroinflammation. 2012 Jul 03;9:159
pubmed: 22759265
J Cereb Blood Flow Metab. 2019 Jan;39(1):3-19
pubmed: 30226080
Am J Physiol. 1984 Jun;246(6 Pt 2):F835-44
pubmed: 6742132
Brain Pathol. 2015 Jan;25(1):35-43
pubmed: 25521175
J Cell Biol. 1998 May 18;141(4):1019-30
pubmed: 9585419
Acta Neuropathol. 2017 Sep;134(3):459-473
pubmed: 28638989
J Cereb Blood Flow Metab. 2016 Jan;36(1):143-57
pubmed: 25853907
Neuron. 2020 Feb 5;105(3):549-561.e5
pubmed: 31810839
Acta Neuropathol. 2016 May;131(5):725-36
pubmed: 26975356
J Neuropathol Exp Neurol. 2003 Feb;62(2):154-61
pubmed: 12578225
Acta Neuropathol. 2016 Sep;132(3):317-38
pubmed: 27522506
Neuroimage Clin. 2019;23:101839
pubmed: 31078937
J Neurosci. 2004 Oct 20;24(42):9282-90
pubmed: 15496664
J Neuropathol Exp Neurol. 1971 Oct;30(4):613-26
pubmed: 5135016
PLoS One. 2019 Jan 25;14(1):e0210888
pubmed: 30682074
Acta Neuropathol. 2015 May;129(5):763-6
pubmed: 25814152
Front Neurosci. 2017 Aug 24;11:475
pubmed: 28883786
Neuropathol Appl Neurobiol. 2013 Oct;39(6):593-611
pubmed: 23489283
Aging Cell. 2013 Apr;12(2):224-36
pubmed: 23413811
Nat Rev Neurol. 2015 Aug;11(8):457-70
pubmed: 26195256
J Cereb Blood Flow Metab. 2013 Jul;33(7):1050-7
pubmed: 23532085
Exp Neurol. 1974 Oct;45(1):50-60
pubmed: 4137563
Clin Sci (Lond). 2018 Apr 30;132(8):851-868
pubmed: 29712883
J Neurooncol. 1997 May;32(3):193-201
pubmed: 9049880
Brain. 1969;92(4):819-28
pubmed: 5364012
Biochim Biophys Acta. 2016 May;1862(5):1037-46
pubmed: 26327684
Ann N Y Acad Sci. 1986;481:123-34
pubmed: 3468852
Neuropathol Appl Neurobiol. 2008 Apr;34(2):131-44
pubmed: 18208483
Front Aging Neurosci. 2019 Jan 23;11:1
pubmed: 30740048
Angiogenesis. 2018 May;21(2):251-266
pubmed: 29299782
Acta Neuropathol. 2012 Mar;123(3):381-94
pubmed: 22170742
J Mol Neurosci. 2016 Jul;59(3):317-25
pubmed: 26590999
AJNR Am J Neuroradiol. 2017 May;38(5):928-934
pubmed: 28364004
Neuropathol Appl Neurobiol. 2004 Aug;30(4):385-95
pubmed: 15305984